ESMO Sarcoma and Rare Cancers | Can BRAF be targeted in brain tumors?

“Enrico Franceschi, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy, Bologna, Italy, comments on BRAF as a targetable mutation in brain tumors. Whilst the BRAF mutations are rare in brain tumors, they are slightly more frequent in gliomas and testing is recommended regardless as BRAF inhibitors are effective in patients who are eligible for them. This interview took place at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.”